Results 191 to 200 of about 36,891 (208)

Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

Circulation, 2023
Yunwen Xu, Alex R Chang, Lesley A Inker
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Alexander S Gallus, Gary Raskob
exaly  

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

Lancet, The, 2012
Renato D Lopes, Sana M Al-Khatib, Lars Wallentin   +2 more
exaly  

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine, 2011
Christopher B Granger, Renato D Lopes, Jack Ansell   +2 more
exaly  

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

New England Journal of Medicine, 2013
Giancarlo Agnelli, Harry R Büller, Alexander T Cohen   +2 more
exaly  

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

Circulation, 2015
Alvaro Aa Avezum, Renato D Lopes, Fernando Lanas   +2 more
exaly  

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

Circulation, 2020
Renato Delascio Lopes, Glenn Chertow, Samira Garonzik   +2 more
exaly  

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

New England Journal of Medicine, 2011
Renato D Lopes, Stefan James, Deepak L Bhatt   +2 more
exaly  

Apixaban for Extended Treatment of Venous Thromboembolism

New England Journal of Medicine, 2013
Giancarlo Agnelli, Harry R Büller, Alexander T Cohen   +2 more
exaly  

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

New England Journal of Medicine, 2019
Marc Carrier, Ranjeeta Mallick, Vicky Tagalakis   +2 more
exaly